Literature DB >> 8201589

N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

J L Neumeyer1, S Wang, Y Gao, R A Milius, N S Kula, A Campbell, R J Baldessarini, Y Zea-Ponce, R M Baldwin, R B Innis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8201589     DOI： 10.1021/jm00037a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  18 in total

1.  Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.

Authors:  H Umesha Shetty; Sami S Zoghbi; Jeih-San Liow; Masanori Ichise; Jinsoo Hong; John L Musachio; Christer Halldin; Jurgen Seidel; Robert B Innis; Victor W Pike
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

2.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Authors:  J Booij; G Tissingh; G J Boer; J D Speelman; J C Stoof; A G Janssen; E C Wolters; E A van Royen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

Review 3.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

4.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

5.  Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors

Authors:  Anna W Sromek; Yu-Gui Si; Tangzhi Zhang; Susan R George; Philip Seeman; John L Neumeyer
Journal:  ACS Med Chem Lett       Date:  2011-03-10       Impact factor: 4.345

Review 6.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-05       Impact factor: 3.825

7.  Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.

Authors:  Jingying Liu; Lin Zhu; Karl Plössl; Brian P Lieberman; Hank F Kung
Journal:  Bioorg Med Chem Lett       Date:  2011-03-21       Impact factor: 2.823

8.  Comparison of 2beta-carbomethoxy-3beta-(4-[18F]fluorophenyl)tropane and N-(3-[18F]fluoropropyl)-2beta-carbomethoxy-3beta-(4-fluorophenyl)nortropane, tracers for imaging dopamine transporter in rat.

Authors:  Päivi Marjamäki; Merja Haaparanta; Sarita Forsback; Veronica Fagerholm; Olli Eskola; Tove Grönroos; Teija Koivula; Olof Solin
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

Review 9.  Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs.

Authors:  Jan Booij; Paul Kemp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-30       Impact factor: 9.236

10.  [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.

Authors:  Christer Halldin; Nina Erixon-Lindroth; Stefan Pauli; Yuan-Hwa Chou; Yoshiro Okubo; Per Karlsson; Camilla Lundkvist; Hans Olsson; Denis Guilloteau; Patrick Emond; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-13       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.